Owlet360 will provide caregivers personalized insights into their infant's health, sleep patterns and development using the company's pediatric health data.
President of Included Health, Robin Cherry Glass, sat down with MobiHealthNews to discuss the company's offerings and activities during the JPM Healthcare Conference.
The funds will be used to increase product offerings, expand the commercial team and move into the substance use disorder space.
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and test that device in clinical trials.
PanopticAI also claims to be the first in the city to obtain US FDA clearance for software as a medical device.
The multifunctional biomedical robot can do imaging, sampling, and laser ablation.
The company will use the funds to scale operations and accelerate its innovation and commercialization initiatives.
The company will use the funds to expand access to its hormonal healthcare platform across the U.S.
The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.
DeepScribe will be the first ambient AI partner for Flatiron Health, and will integrate with Flatiron's OncoEMR.
